This legislation aims to enhance the regulation of synthetic analogues of controlled substances, particularly those imported into the United States, in order to prevent abuse and protect public health. It clarifies the classification and control of these substances under the Controlled Substances Act, introducing a new category called Schedule A. This category encompasses substances with chemical structures similar to existing controlled substances that exhibit similar effects on the central nervous system.